The invention relates to novel tetrahydroisoquinoline derivatives of general formula I and theirs use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and their use as anti-infectives, wherein R
1
, R
2
and R
3
are as defined in claim 1.
本发明涉及一种新型
四氢异喹啉衍
生物,其通式为I,并且它们作为制备药物组成物的活性成分的用途。本发明还涉及相关方面,包括制备化合物的过程,含有其中一种或多种化合物的制药组合物以及它们作为抗感染药物的用途,其中R1、R2和R3如权利要求1所定义。